Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 63,749 | 10,794 | 11,950 | 3,560 | 2,172 |
| Cost of Goods | 43,106 | 1,094 | 553 | 577 | 371 |
| Gross Profit | 20,643 | 9,700 | 11,397 | 2,983 | 1,801 |
| Operating Expenses | 33,956 | 27,377 | 25,380 | 24,818 | 25,348 |
| Operating Income | -13,207 | -17,583 | -13,430 | -21,258 | -23,176 |
| Interest Expense | 5,700 | 0 | 0 | 0 | 0 |
| Other Income | 255 | 180 | 167 | 137 | 98 |
| Pre-tax Income | -18,652 | -17,403 | -13,263 | -21,121 | -23,078 |
| Net Income Continuous | -18,652 | -17,403 | -13,263 | -21,121 | -23,078 |
| Net Income | $-18,652 | $-17,403 | $-13,263 | $-21,121 | $-23,078 |
| EPS Basic Total Ops | -0.57 | -0.51 | -0.45 | -0.72 | -0.79 |
| EPS Basic Continuous Ops | -0.57 | -0.52 | -0.45 | -0.72 | -0.79 |
| EPS Diluted Total Ops | -0.57 | -0.51 | -0.45 | -0.72 | -0.79 |
| EPS Diluted Continuous Ops | -0.57 | -0.52 | -0.45 | -0.72 | -0.79 |
| EBITDA(a) | $16,801 | $-17,453 | $-13,298 | $-21,134 | $-22,968 |